We are very pleased and honored to announce that we will be giving a presentation titled “Asset Management Best Practices” at BIOCOM CRO Event on September 22.
Our speaker and stability storage process consultant, Gary Ostermiller is an experienced stability professional with extensive experience in pharmaceutical stability operations. He has an excellent background in facility design & operation, stability storage and the related regulations.
Come join us at BIOCOM CRO Best Practice Series Event.
We are looking forward to meeting you on September 22 in San Diego.
With the rising cost of getting a drug to market, it is more important now than ever to carefully manage your budget and ensure that you are allocating spend appropriately. One area that frequently has a mis, or NON managed budget, is an organization’s asset management program. In a mid-sized biotech, hundreds of thousands, if not millions of dollars, are spent on purchasing new equipment, keeping high dollar assets under service contract, and managing the break/fix, PM, calibration of existing assets; and this does not even consider the soft costs associated with the administrative burden of keeping your assets functioning.
What about your organization? Do you know what the percent utilization of your key equipment is? Do you know what assets are covered under service contract, do you know if those assets SHOULD be under contract? Do you know how well your assets are performing? Percent downtime? Length of life cycle? How that affects productivity in your lab?
Explore why these, and so many more questions are important in defining a functional, useful, and valuable asset management plan that will not only improve the efficiency and operation of your lab, but will most likely save you money.